Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorth

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Cancer|March 11, 2026
Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinomaLisa A Kachnic, Jennifer Moughan, Theodore S Hong, et al.
JAMA Oncology|December 19, 2024
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical TrialLaura A Dawson, Kathryn A Winter, Jennifer J Knox, et al.
Journal of Applied Clinical Medical Physics|August 3, 2022
Abdominopelvic MR to CT registration using a synthetic CT intermediateJin Uk Heo, Feifei Zhou, Robert Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2022
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504Maura L Gillison, Robert L Ferris, Jonathan Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck CancerMitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck CancerSri Vemulamanda, Aditi Kothari, Loris De Cecco, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Cancer|March 11, 2026
Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinomaLisa A Kachnic, Jennifer Moughan, Theodore S Hong, et al.
JAMA Oncology|December 19, 2024
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical TrialLaura A Dawson, Kathryn A Winter, Jennifer J Knox, et al.
Journal of Applied Clinical Medical Physics|August 3, 2022
Abdominopelvic MR to CT registration using a synthetic CT intermediateJin Uk Heo, Feifei Zhou, Robert Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2022
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504Maura L Gillison, Robert L Ferris, Jonathan Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck CancerMitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck CancerSri Vemulamanda, Aditi Kothari, Loris De Cecco, et al.
Pageof 10